Novigenix Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Novigenix General Information

Description

Developer of a precision medicine platform designed for the detection of disease, therapy optimization, and disease recurrence monitoring. The company's platform is optimized for mapping the response of the immune system to the onset and progression of the disease by integrating patient multi-omics data, advanced machine learning, and artificial intelligence (AI) approaches, providing medical professionals with actionable insights and precision tools for the optimization of patients' therapeutic journey.

Contact Information

Website
www.novigenix.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Route de la Corniche 3
  • Phenyl Building, Biopôle IV
  • 1066 Epalinges
  • Switzerland
+41 021
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Decision/Risk Analysis
Diagnostic Equipment
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • Route de la Corniche 3
  • Phenyl Building, Biopôle IV
  • 1066 Epalinges
  • Switzerland
+41 021

Novigenix Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novigenix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 18-Feb-2025 Completed Generating Revenue
2. Later Stage VC (Series B) 15-Nov-2022 Completed Generating Revenue
1. Grant 21-Jan-2021 $1.22M Completed Startup
To view Novigenix’s complete valuation and funding history, request access »

Novigenix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision medicine platform designed for the detection of disease, therapy optimization, and disease recu
Other Healthcare Technology Systems
Epalinges, Switzerland
26 As of 2025

San Diego, CA
 

Tolochenaz, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novigenix Competitors (31)

One of Novigenix’s 31 competitors is Epic Sciences, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Epic Sciences Venture Capital-Backed San Diego, CA
Lunaphore Formerly VC-backed Tolochenaz, Switzerland
Akonni Biosystems Venture Capital-Backed Frederick, MD
Cepheid Formerly VC-backed Sunnyvale, CA
Boreal Genomics Formerly VC-backed Vancouver, Canada
You’re viewing 5 of 31 competitors. Get the full list »

Novigenix Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Novigenix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4526473-A2 Biomarkers for colorectal neoplasia Pending 20-May-2022
CA-3192695-A1 Biomarkers for immune checkpoint inhibitors treatment Pending 16-Sep-2020
EP-4214334-A1 Biomarkers for immune checkpoint inhibitors treatment Pending 16-Sep-2020
US-20230340611-A1 Biomarkers for immune checkpoint inhibitors treatment Pending 16-Sep-2020
US-20230026559-A1 Analysis of cell signatures for disease detection Pending 10-Dec-2019 C12Q1/6886
To view Novigenix’s complete patent history, request access »

Novigenix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novigenix Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Microsoft for Startups Accelerator/Incubator
Eurostars Other
To view Novigenix’s complete investors history, request access »

Novigenix Acquisitions (1)

Novigenix’s most recent deal was a Merger/Acquisition with Diagnoplex. The deal was made on 12-Feb-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Diagnoplex 12-Feb-2015 Merger/Acquisition Laboratory Services (Healthcare)
To view Novigenix’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Novigenix FAQs

  • When was Novigenix founded?

    Novigenix was founded in 2014.

  • Where is Novigenix headquartered?

    Novigenix is headquartered in Epalinges, Switzerland.

  • What is the size of Novigenix?

    Novigenix has 26 total employees.

  • What industry is Novigenix in?

    Novigenix’s primary industry is Other Healthcare Technology Systems.

  • Is Novigenix a private or public company?

    Novigenix is a Private company.

  • What is Novigenix’s current revenue?

    The current revenue for Novigenix is .

  • How much funding has Novigenix raised over time?

    Novigenix has raised $20M.

  • Who are Novigenix’s investors?

    Microsoft for Startups and Eurostars have invested in Novigenix.

  • Who are Novigenix’s competitors?

    Epic Sciences, Lunaphore, Akonni Biosystems, Cepheid, and Boreal Genomics are some of the 31 competitors of Novigenix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »